1953-04-4 Galantamine hydrobromide AKSci J10353
 
 
Loading Please Wait...
  J10353    AKSci Reference Standard
Galantamine hydrobromide, >98% (HPLC)
 
Nivalin
Razadyne
IDENTITY
CAS Number:1953-04-4
MDL Number:MFCD00067672
MF:C17H22BrNO3
MW:368.27
EINECS:217-780-5
BRN:3787265
SPECIFICATIONS & PROPERTIES
Purity:>98% (HPLC)
Spectra:LCMS, HPLC, Polarimetry
Physical Form:White to off-white to light yellow powder or crystals
Melting Point:256°C
Optical Rotation:-92.0 to -98.0° (c=1.4, H2O)
Long-Term Storage:Store long-term at -20°C
UN #:UN2811
Hazard Class:6.1; Poison
Packing Group:III

BIOLOGICAL INFO
Solubility:Water: 20mg/mL; Soluble in ethanol
Application(s):Reversible acetylcholinesterase inhibitor

REVIEW
 Galantamine is a phenanthrene alkaloid and a reversible, competitive acetylcholinesterase inhibitor. It is not structurally related to other acetylcholinesterase inhibitors. Galantamine''s proposed mechanism of action involves the reversible inhibition of acetylcholinesterase, which prevents the hydrolysis of acetycholine, leading to an increased concentration of acetylcholine at cholinergic synapses. Galantamine also binds allosterically with nicotinic acetylcholine receptors and may possibly potentiate the action of agonists (such as acetylcholine) at these receptors.

REFERENCES
[1]Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer''s disease. Drugs. 2000 Nov;60(5):1095-122.
[2] Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL: Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution. FEBS Lett. 1999 Dec 17;463(3):321-6.
[3] Woodruff-Pak DS, Vogel RW 3rd, Wenk GL: Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94. Epub 2001 Feb 6.
[4] Birks J: Cholinesterase inhibitors for Alzheimer''s disease. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Pubmed# Lilienfeld S: Galantamine-a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer''s disease. CNS Drug Rev. 2002 Summer;8(2):159-76.

GHS

Pictograms

Signal Word
Danger

Hazard Statements
H301

Precautionary Statements
P264; P270; P301+P310; P321; P330; P405; P501

Current as of July 11, 2020

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS

For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.


CATEGORIES
 APIs and Bioactives > AChR Agonists, Alzheimer's


PubChem